Respirology Case Reports (May 2021)

Autologous adipose‐derived stem cells therapy in COPD treatment: a case report

  • Thuy Thanh Nguyen,
  • Phuong Thu Phan,
  • Binh Huy Nguyen,
  • Trang T. Thu Vu,
  • Phuong Cam Pham,
  • Giap Van Vu,
  • Khanh Ba Nguyen,
  • Trung Thanh Vu,
  • Luu Dang Vu,
  • Chau Quy Ngo

DOI
https://doi.org/10.1002/rcr2.748
Journal volume & issue
Vol. 9, no. 5
pp. n/a – n/a

Abstract

Read online

Abstract Here, we describe the clinical course of a patient with chronic obstructive pulmonary disease treated with autologous adipose‐derived stem cell therapy. In September 2019, our patient was admitted to Bach Mai Hospital. His post‐bronchodilator forced expiratory volume in 1 sec (FEV1) was 21% and FEV1/forced vital capacity (FVC) was 40%. He had suffered from two exacerbations of chronic obstructive pulmonary disease (COPD) in the previous year. He received treatment with autologous stem cells from adipose tissue. Follow‐up indicated that autologous stem cells from adipose tissue was a safe treatment and improved the patient's dyspnoea and quality of life.

Keywords